European journal of obstetrics, gynecology, and reproductive biology, 2000
Abstract
Objective
Evaluation of sensitivity and specificity of 4 ultrasound indices of ovulation.
Study Design
Multicenter collaborative study of 794 abdominal and transvaginal ultrasound scanning of ovaries performed during 271 cycles in 107 normally fertile women. Comparison of sensitivities and specificities of indices using McNemar test.
Results
The sensitivity and specificity of the indices were 84 and 89.2, respectively, for disappearance or sudden decrease in follicle size; 38.4 and 79.7 for appearance of ultrasonic echoes in the follicle; 61.6 and 87.1 for irregularity of follicular walls; 71.0 and 88.2 for appearance of free fluid in the cul-de-sac of Douglas.
Conclusion
Ultrasonic echoes had a significantly lower sensitivity (P<0.001) and specificity (P<0.01) than other indices.
Topics
PMID 10817880 10817880 DOI 10.1016/s0301-2115(99)00249-3 10.1016/s0301-2115(99)00249-3 Ecochard et al. 2000, Ecochard 2000
Related articles
Ultrasound · Follicular Monitoring
Using corpus luteum formation with dominant follicle collapse to improve the criteria for identifying ovulation
Bouchard TP et al., 2026 · Reproductive biomedicine online
Does formation of the corpus luteum help to identify the day of ovulation on ultrasound when follicular collapse is missed, and how reliable are sonographers versus a review panel in identifying the day of ovulation on ultrasound? Sonographers in a clinic in Canada performed serial endovaginal ultrasound scans (six to eight per cycle) to identify the day of ovulation in regularly cycling women (n = 40) who were followed for one to five cycles (n = 85). The day of ovulation was identified by: (i) identification of the dominant follicle; (ii) disappearance of the dominant follicle; and (iii) identification and dating of the corpus luteum. The main outcome measures were inter-rater reliability between two sonographers, and Bland-Altman agreement between the supervising sonographer and a panel that reviewed each scan to identify the day of ovulation. Of the 85 menstrual cycles reviewed, two cycles did not have sufficient data to date ovulation, one cycle showed an incidental dermoid cyst, and 11 cycles showed anovulatory patterns. This left a total of 71 cycles (84%) for which intra-rater reliability between two sonographers for identifying the day of ovulation was high (intraclass correlation coefficient = 0.99, P < 0.0001), and Bland-Altman agreement showed no significant difference in the estimated day of ovulation between the supervising sonographer and the panel (t = -0.28, P = 0.78). Corpus luteum criteria were necessary to help identify the day of ovulation in 14 of 71 cycles (20%). The estimated day of ovulation can be determined reliably on ultrasound by trained sonographers using collapse of the dominant follicle and formation of the corpus luteum based on six to eight scans per cycle.
Luteal Phase · Corpus Luteum Function
Timing luteal urinary pregnanediol glucuronide assessment using urinary luteinizing hormone: agreement with ultrasound-determined ovulation
Leiva R et al., 2026 · SSRN Electronic Journal
Background,Pregnanediol glucuronide (PdG), the principal urinary metabolite of progesterone, can assess luteal progesterone exposure, but interpretation depends on appropriate timing relative to ovulation. We evaluated whether urinary luteinizing hormone (LH)-based reference points could standardize luteal urinary PdG assessment compared with ultrasound-determined ovulation (USDO).,Methods,This retrospective secondary analysis included 216 ovulatory cycles from 95 women from an original cohort of 107 women (326 cycles). Eligible cycles had ultrasound-confirmed ovulation and an LH peak before USDO+3. The retrospectively identified LH peak and first urinary LH concentrations ≥10, ≥15, ≥20, ≥25, and ≥30 mIU/mL were evaluated for timing urinary PdG measurement 6–9 days later, using a prespecified threshold of ≥15 µg/mL. PdG classifications were compared with USDO-timed classifications using area under the receiver operating characteristic curve, sensitivity, specificity, predictive values, and likelihood ratios.,Results,Agreement remained high across assessment days. The LH peak showed the highest overall agreement. Among prospectively applicable strategies, first urinary LH ≥15 mIU/mL provided the best balance between agreement and cycle availability. Positive predictive values were consistently high (98–100%), whereas negative predictive values were modest. No assessment day consistently outperformed the others.,Conclusions,Urinary LH-based timing closely reproduced USDO-guided urinary PdG classification. The LH peak showed the highest agreement, whereas first urinary LH ≥15 mIU/mL was the most practical prospective reference point. PdG ≥15 µg/mL classifications showed near-universal agreement with ultrasound-guided timing. These findings support standardized PdG timing when ultrasound is unavailable but do not establish diagnostic criteria or predict reproductive outcomes.
Measurement and Statistics · Instrument Development and Validation
Validating At-Home Urinary Hormone Measurements in Postpartum and Perimenopause Fertility Transitions
Bouchard TP et al., 2025 · Womens Health Rep (New Rochelle) · Open Access
Measuring quantitative menstrual cycle hormones at home may help women better understand their postpartum and perimenopause fertility transitions, but these quantitative fertility monitors require validation. This study included 16 North American women, aged 28-51, during either the postpartum (n = 8, cycles = 18) or perimenopause (n = 8, cycles = 35) fertility transitions testing daily first-morning urine testing with both the Mira Monitor and ClearBlue Fertility Monitor (CBFM) along with menstrual cycle parameter tracking. The main outcome measures were a rise in estrone-3-glucuronide (E13G) and luteinizing hormone (LH) urine hormone values from the Mira monitor correlated to low, high, or peak values on the CBFM. Both in the postpartum and perimenopause transitions, the identification of the day of ovulation based on the LH surge on the Mira and CBFM monitors was highly correlated (R = 0.94 and 0.83, p < 0.001). The E13G levels on the Mira monitor were significantly higher for a CBFM reading of "High" compared with "Low" for both the postpartum and perimenopausal cycles (all p < 0.001). Similarly, the LH levels on the Mira monitor were significantly higher for a CBFM reading of "Peak" (LH surge) compared with "High" for both the postpartum and perimenopausal cycles (all p < 0.001). The LH surge and levels of E13G in urine identified on the quantitative Mira fertility monitor strongly correlate to the LH surge and the shift from low to high on the CBFM during the postpartum and perimenopause transitions.
Effectiveness · Comparative Effectiveness
A Comparison of Two Hormonal Fertility Monitoring Systems for Ovulation Detection: A Pilot Study
Mu Q et al., 2023 · Medicina (Kaunas) · Open Access
Background and Accuracy in detecting ovulation and estimating the fertile window in the menstrual cycle is essential for women to avoid or achieve pregnancy. There has been a rapid growth in fertility apps and home ovulation testing kits in recent years. Nevertheless, there lacks information on how well these apps perform in helping users understand their fertility in the menstrual cycle. This pilot study aimed to evaluate and compare the beginning, peak, and length of the fertile window as determined by a new luteinizing hormone (LH) fertility tracking app with the Clearblue Fertility Monitor (CBFM). A total of 30 women were randomized into either a quantitative Premom or a qualitative Easy@Home (EAH) LH testing system. The results of the two testing systems were compared with the results from the CBFM over three menstrual cycles of use. Potential LH levels for estimating the beginning of the fertile window were calculated along with user acceptability and satisfaction. The estimates of peak fertility by the Premom and EAH LH testing were highly correlated with the CBFM peak results (R = 0.99, p < 0.001). The participants had higher satisfaction and ease-of-use ratings with the CBFM compared to the Premom and EAH LH testing systems. LH 95% confidence levels for estimating the beginning of the fertile window were provided for both the Premom and EAH LH testing results. Our pilot study findings suggest that the Premom and EAH LH fertility testing app can accurately detect impending ovulation for women and are easy to use at home. However, successful utilization of these low-cost LH testing tools and apps for fertility self-monitoring and family planning needs further evaluation with a large and more diverse population.